Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 541.00
Bid: 539.00
Ask: 541.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.371%)
Open: 538.00
High: 543.00
Low: 538.00
Prev. Close: 541.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AuM Update

14 Apr 2022 07:00

RNS Number : 3267I
Polar Capital Holdings PLC
14 April 2022
 

14 April 2022 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of Assets under Management ("AUM") for the financial year to 31 March 2022.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2022 its AuM were £22.1bn compared to £20.9bn at the end of March 2021, an increase of 6% over the period. During the period, AuM increased by £1.2bn which comprised net inflows of £0.4bn, and an increase of £0.8bn relating to market movement and fund performance.

 

AuM movement in twelve months to 31 March 2022

Open ended

funds

Investment Trusts

Segregated mandates

Total

AuM at 1 April 2021

£16,579m

£3,867m

£417m

£20,863m

Net subscriptions/(redemptions)

£(544)m

£190m

£745m

£391m

Market movement

and performance

£555m

£321m

£(9)m

£867m

Total AuM at 31 March 2022

£16,590m

£4,378m

£1,153m

£22,121m

 

 

Gavin Rochussen, Chief Executive, commented:

 

"A combination of net inflows, market uplift and outperformance enabled our AuM to increase by 6% over the financial year from £20.9bn to £22.1bn.

 

"Despite the market backdrop, net flows over the financial year have been resilient with notable success in the net funding of segregated mandates amounting to £745m, taking total segregated AuM to £1.2bn, which now represents around 5% of total AuM at 31 March 2022.

 

"Our diversification strategy is yielding results with net inflows in the quarter of £230m into our sustainable Emerging Markets Stars and sustainable Smart Energy and Smart Mobility strategies. This includes an early success in the funding of a segregated mandate for the sustainable Smart Energy strategy.

 

"Over the year there has been strong progress in increasing the exposure Polar has in strategies other than its core Technology funds. The rotation away from high-growth stocks and pandemic winners has seen net outflows of £1.3bn from the Technology funds, though these have been more than offset by net inflows of £873m into the Polar Capital Sustainable Emerging Market Stars strategy, £561m into the Healthcare strategy, £143m into the Convertible funds, £85m into the European Opportunities fund and £120m into the recently launched sustainable Smart Energy and Smart Mobility strategy. A healthy proportion of these inflows has been from regions and clients who are new to our business, a further success of our diversification strategy.

 

"With the onset of inflation and more hawkish central bank policy globally, rate rise expectations have caused higher growth equities to de-rate. This impacted our larger sector-focused strategies such as Technology and Healthcare in the short term. Shorter term fund performance across our fund range has consequently been challenging with 43% of our funds outperforming benchmark over the calendar year to 31 March 2022.

 

"Longer term performance remains strong with 84% of AuM in our UCITS fund range ranked in the top two quartiles against peers in the Lipper universe over three years.

 

"Tightening rates and the invasion of Ukraine led to investors reducing weightings to riskier growth asset classes during the last three months. In the quarter, Polar had net outflows of £411m of which £630m were from our Technology funds. This was offset by net inflows of £170m into our sustainable Emerging Market Stars funds, £70m into the Insurance fund, £86m of share issuance by the Polar Capital Financials Trust and £60m net inflows into the recently launched sustainable Smart Energy and Smart Mobility funds.

 

"We recently announced that the Board of the two US mutual funds, Phaeacian Accent International Value Fund and the Phaeacian Global Value Fund, decided to close the funds with effect from 26 May 2022. The closure of the funds is immaterial to the core profitability of the Group and we continue to develop our U.S. footprint.

 

"The pipeline for flows remains strong for both our Emerging Markets Stars range of funds, which have sustainability at the core of their processes, as well as for the two recently launched Article 9 funds, Polar Capital Smart Energy Fund, and the Polar Capital Smart Mobility Fund, which form part of Polar Capital's sustainable investment strategies.

 

"It was also pleasing to see that Polar Capital scored well in the annual Broadridge survey of investment professionals. Within the UK, we were the 8th highest rank brand, the smallest group in the top ten and in the company of many much larger peers. Our approach has always been to deliver a specialist investment offering with a premium service to our clients and therefore, it was also pleasing to see Polar ranked number 1 for Thematic Equity in the UK and scoring top-ten positions for both client communication and client-oriented thinking.

 

"We remain confident that, with our diverse range of complementary funds and focus on performance in our actively managed strategies, we are positioned to continue to perform well for our clients and will continue to generate net inflows."

 

Polar Capital aims to announce its results for the financial year to 31 March 2022 on 27 June 2022.

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)

Samir Ayub (Finance Director)

 

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Giles Rolls

Charles Farquhar

Stephen Westgate

 

+44 (0)20 7260 1000

 

 

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Rishi Shah

 

 

 

+44 (0)20 3597 8680

 

Camarco

Ed Gascoigne-Pees

Jennifer Renwick

Monique Perks

Phoebe Pugh

 

+44 (0)20 3757 4995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKLDFEKAEFA
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.